These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15690586)

  • 21. [What is epigenetics? Strategies for research and application to cancer].
    Van Seuningen I
    Ann Pathol; 2009 Nov; 29 Spec No 1():S28-30. PubMed ID: 19887245
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings of the Symposium on Cell Kinetics and Cancer Chemotherapy (Annapolis, Maryland, November 4-6, 1975): Introduction to session on recruitment and synchrony--in vitro.
    Baserga R
    Cancer Treat Rep; 1976 Dec; 60(12):1811-2. PubMed ID: 1026337
    [No Abstract]   [Full Text] [Related]  

  • 23. A biography and bibliography: the recent trends in bioethics and medical genetics in Japan (Part I).
    Fujiki N
    Rev Derecho Genoma Hum; 2000; (12):173-90. PubMed ID: 11147207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to identification of biomarkers for early cancer detection: The Thirteenth International Symposium of the Hiroshima Cancer Seminar, October 2003.
    Yasui W; Hirohashi S; Imai K; Tahara E
    Cancer Sci; 2004 Feb; 95(2):193-5. PubMed ID: 14965372
    [No Abstract]   [Full Text] [Related]  

  • 25. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.
    Recillas-Targa F; De La Rosa-Velázquez IA; Soto-Reyes E; Benítez-Bribiesca L
    J Cell Mol Med; 2006; 10(3):554-68. PubMed ID: 16989720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin modification and disease.
    Johnson CA
    J Med Genet; 2000 Dec; 37(12):905-15. PubMed ID: 11106353
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer genomics and molecular diagnosis--The Nineteenth International Symposium of Sapporo Cancer Seminar.
    Perucho M; Tokino T; Nakamura Y
    Jpn J Cancer Res; 1999 Nov; 90(11):1273-6. PubMed ID: 10622541
    [No Abstract]   [Full Text] [Related]  

  • 28. [23d congress of the Japan Society for Cancer Therapy. Hiroshima, 14 to 16 November, 1985. Abstracts].
    Nihon Gan Chiryo Gakkai Shi; 1985 Sep; 20(8):1449-2009. PubMed ID: 4086932
    [No Abstract]   [Full Text] [Related]  

  • 29. Looking Back at the 30th Nagoya International Cancer Treatment Symposium.
    Naoe T
    Oncology; 2015; 89 Suppl 1():IV. PubMed ID: 26551512
    [No Abstract]   [Full Text] [Related]  

  • 30. Histone acetylation and chromatin pattern in cancer. A review.
    Orr JA; Hamilton PW
    Anal Quant Cytol Histol; 2007 Feb; 29(1):17-31. PubMed ID: 17375871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biology. Genetic events that shape the cancer epigenome.
    Ryan RJ; Bernstein BE
    Science; 2012 Jun; 336(6088):1513-4. PubMed ID: 22723401
    [No Abstract]   [Full Text] [Related]  

  • 32. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatin states define tumour-specific T cell dysfunction and reprogramming.
    Philip M; Fairchild L; Sun L; Horste EL; Camara S; Shakiba M; Scott AC; Viale A; Lauer P; Merghoub T; Hellmann MD; Wolchok JD; Leslie CS; Schietinger A
    Nature; 2017 May; 545(7655):452-456. PubMed ID: 28514453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New trends in cancer for the 21st Century. Proceedings of the International Symposium on Cancer. Valencia, Spain. November 10-13, 2002.
    Adv Exp Med Biol; 2003; 532():1-276. PubMed ID: 14746332
    [No Abstract]   [Full Text] [Related]  

  • 35. Eleventh annual Pezcoller Symposium: molecular horizons in cancer therapeutics.
    Mihich E; Livingston D
    Cancer Res; 2000 Feb; 60(3):768-73. PubMed ID: 10676667
    [No Abstract]   [Full Text] [Related]  

  • 36. Chromatin repressive complexes in stem cells, development, and cancer.
    Laugesen A; Helin K
    Cell Stem Cell; 2014 Jun; 14(6):735-51. PubMed ID: 24905164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Japan-Korea Cancer Research Symposium: investigation on the balanced cooperation of cancer cells with the human body.
    Park SC; Lim IK; Paik NS; Yamamoto T; Yuasa Y; Nakachi K; Fujiki H
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):692-5. PubMed ID: 11710600
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular responses to DNA damage: current state of the field and review of the 52nd Benzon Symposium.
    Lukas J; Bohr VA; Halazonetis TD
    DNA Repair (Amst); 2006 May; 5(5):591-601. PubMed ID: 16504601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linking Heterochromatin Protein 1 (HP1) to cancer progression.
    Dialynas GK; Vitalini MW; Wallrath LL
    Mutat Res; 2008 Dec; 647(1-2):13-20. PubMed ID: 18926834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromatin signatures of cancer.
    Morgan MA; Shilatifard A
    Genes Dev; 2015 Feb; 29(3):238-49. PubMed ID: 25644600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.